TONI SANTIAGO: Open Payments
NPI 1215150636 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,996 in 101 payments from 18 companies in 2025. Trend: 2023 $2,146 · 2024 $1,353 · 2025 $2,996
Food & beverage: $2,901Education: $95
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $541 |
| ARS Pharmaceuticals Operations, Inc. | 11 | $422 |
| Genentech USA, Inc. | 13 | $413 |
| GlaxoSmithKline, LLC. | 17 | $409 |
| Novartis Pharmaceuticals Corporation | 9 | $181 |
| CSL Behring | 2 | $180 |
| Regeneron Healthcare Solutions, Inc. | 5 | $160 |
| REVANCE THERAPEUTICS, INC. | 1 | $135 |
| ABBVIE INC. | 1 | $130 |
| GENZYME CORPORATION | 5 | $127 |
Products named: XOLAIR, NEFFY, NUCALA, AIRSUPRA, DUPIXENT, TEZSPIRE, Haegarda, DAXXIFY.
Industry payments across NY — which companies pay providers there.
